Cart 0
Medical cannabis, known as Cannabis-Based Products for Medicinal Use (CBPMs), is legal in the UK for specific medical conditions. It’s prescribed only by specialist doctors registered with the General Medical Council (GMC) when other treatments have failed. Here’s what you need to know:
- Eligibility: You must have a diagnosed condition that hasn’t improved with at least two conventional treatments. Commonly considered conditions include chronic pain, epilepsy, multiple sclerosis, PTSD, and Crohn’s disease.
- Access: NHS access is limited to three licensed medications (Sativex, Epidyolex, Nabilone) for specific conditions. Most patients (99%) obtain prescriptions through private clinics, which offer broader treatment options.
- Costs: Private treatment involves consultation fees (£50–£200) and monthly medication costs (£150–£500). Clinics may offer subscription plans or payment options to manage expenses.
- Process: Gather medical records, self-refer to a private clinic, and complete a video consultation with a GMC-approved doctor. If eligible, prescriptions are issued and medication delivered securely.
While access via the NHS remains rare, private clinics provide faster and more flexible options for patients seeking relief. Always ensure you meet eligibility criteria and understand the costs involved before starting the process.
Who Qualifies for Medical Cannabis in the UK
Basic Requirements for Eligibility
In the UK, eligibility for medical cannabis hinges on having a diagnosed physical or mental health condition that hasn’t responded to at least two conventional treatments.
The decision to prescribe medical cannabis is made by a specialist registered with the General Medical Council (GMC), not by a GP. These specialists carefully evaluate your medical history and previous treatments to determine if cannabis-based treatment could be beneficial.
There’s no legal minimum age for obtaining a medical cannabis prescription. That said, patients under 25 often undergo more rigorous evaluation, and those under 18 must be assessed by a paediatric specialist.
To support your application, you’ll need to provide comprehensive medical records, including details of your diagnosis, past treatments, and their outcomes. If you’ve received treatment abroad or recently moved to the UK, ensure your medical documents are organised and ready in advance.
Interestingly, clinics generally don’t disqualify patients who have previously used cannabis illicitly, provided it was for genuine symptom relief.
Now, let’s explore the specific conditions that are commonly considered for treatment.
Medical Conditions That Qualify
The UK doesn’t have a fixed list of conditions that qualify for medical cannabis. Instead, each case is reviewed individually to assess clinical evidence and potential benefit. However, certain conditions are more frequently considered:
- Chronic Pain Conditions: This includes nerve pain, fibromyalgia, arthritis, and chronic back pain that hasn’t improved with standard treatments.
- Neurological Disorders: Conditions like multiple sclerosis, particularly with spasticity, and treatment-resistant epilepsy are often considered.
- Mental Health Conditions: Cannabis may be an option for generalised anxiety disorder, post-traumatic stress disorder (PTSD), and severe sleep disturbances that haven’t responded to other treatments.
- Cancer-Related Symptoms: It can help manage chemotherapy-induced nausea, vomiting, pain, and appetite loss. Similar benefits are sometimes seen in patients with HIV/AIDS.
- Gastrointestinal Conditions: This includes Crohn’s disease, inflammatory bowel disease, and irritable bowel syndrome.
- Other Conditions: Migraines, cluster headaches, autism spectrum disorders, and some dermatological conditions may also qualify.
NHS vs Private Clinic Access
Eligibility aside, how you access medical cannabis in the UK depends on whether you go through the NHS or a private clinic. It’s worth noting that NHS prescriptions are very limited, covering only three conditions approved by NICE: chemotherapy-induced nausea and vomiting, MS-related spasticity, and severe treatment-resistant epilepsy. In reality, NHS prescriptions are rare – around 99% of patients access treatment through private clinics.
Here’s a comparison of the two routes:
| Access Route | Conditions Treated | Cost | Waiting Time | Prescribing Doctor |
|---|---|---|---|---|
| NHS | Limited to chemotherapy-induced nausea, MS-related spasticity, and treatment-resistant epilepsy | Free at the point of use | Typically longer | Hospital specialist |
| Private Clinics | Broader range, including chronic pain, PTSD, anxiety, epilepsy, migraines, Crohn’s disease, and more | Patient pays (varies) | Generally faster | GMC-registered specialist |
Private clinics are often the more practical option for most patients. They provide a wider scope of treatment options, faster access to care, and personalised attention. For example, Elios Clinics focuses on treating chronic pain, psychiatric, and neurological conditions with medical cannabis. Their services include eligibility assessments, video consultations with GMC-approved doctors, and customised treatment plans, with some even offering next-day medication delivery.
Unlike the NHS, private clinics allow you to self-refer, so you don’t need a GP referral to start the process. This direct approach often means quicker access to treatment, though you’ll need to cover the costs of consultations, prescriptions, and follow-ups.
For many in the UK, private clinics remain the most practical route to accessing medical cannabis. They offer a broader range of treatments, faster service, and access to experienced specialists, making them a preferred choice for patients seeking relief.
How to Get Assessed and Prescribed Medical Cannabis
Initial Eligibility Assessment
The first step is to gather detailed medical records showing you’ve tried at least two conventional treatments without success. Many private clinics provide free eligibility assessments to help determine if medical cannabis might be an option for you. During this stage, you’ll fill out a questionnaire covering your medical history, current symptoms, and previous treatments. It’s a simple process, and you can self-refer, though obtaining your medical records from your GP may take up to 28 working days. Make sure your records are current and easy to access.
Once your records are reviewed, eligible patients are usually invited to book an appointment within three working days. This quick process means you can move forward without lengthy delays. After your records are verified, you can proceed directly to scheduling your consultation.
Consultation and Prescription Process
Your next step is booking a 30–60-minute video consultation with a doctor approved by the General Medical Council (GMC). During the consultation, the doctor will examine your medical history, discuss your symptoms, and explore why traditional treatments haven’t worked for you.
The doctor will ask about how your condition affects your daily life, your current medications, and any prior experience with cannabis. They’ll also explain the potential benefits and risks of using medical cannabis to ensure you’re fully informed. If the assessment is positive, the doctor can issue a prescription under strict guidelines for controlled substances, on a ‘named patient’ basis. Before final approval, your case may be reviewed by a multidisciplinary team, which typically takes one to two weeks. Once approved, the prescription is sent to a specialist pharmacy, where you’ll need to pay for your medication before it’s shipped.
Many clinics, such as Elios Clinics, offer next-day delivery after payment. This means your medication could arrive within 24 hours of prescription approval. Delivery is handled by a secure courier, ensuring both safety and privacy. From here, your treatment journey continues with regular follow-ups.
Follow-Up Care and Monitoring
After receiving your first prescription, regular monitoring ensures the treatment is working effectively and allows for adjustments if needed. Clinics schedule follow-up appointments to track your progress and address any concerns.
"We systematically establish trust and communicate clearly with our patients. We arrange follow-up appointments to monitor our patients’ progress, adjust treatments, or make further assessments." – Elios Clinics
These follow-up consultations, often conducted via video call, give your doctor the chance to fine-tune your treatment. They’ll evaluate how well the medication is working, check for any side effects, and adjust dosages or strains as necessary. This ongoing support is essential – what works initially may need adjustments as your body adapts.
Beyond managing prescriptions, clinics provide additional support, such as guidance on proper use, advice on handling side effects, and assistance with travel documentation if you need to take your medication abroad. Many clinics also collaborate with your existing healthcare team to ensure your medical cannabis treatment fits seamlessly into your broader care plan.
Types of Medical Cannabis Products Available
Licensed and Unlicensed Products
In the UK, medical cannabis falls into two categories: licensed medicines and unlicensed cannabis-based products for medicinal use (CBPMs). This classification significantly influences treatment options.
Licensed cannabis medicines are those that have passed rigorous clinical trials and received full approval from the Medicines and Healthcare products Regulatory Agency (MHRA). Currently, only three products hold this status: Sativex, used for managing spasticity in multiple sclerosis; Epidyolex, prescribed for severe epilepsy; and Nabilone, aimed at controlling chemotherapy-induced nausea. These medicines have been rescheduled out of Schedule 1 of the Misuse of Drugs Regulations 2001 and may be funded by the NHS, but only for specific conditions.
On the other hand, unlicensed CBPMs make up the majority of medical cannabis prescriptions in the UK. These are prescribed under "special clinical need criteria" when licensed alternatives are unsuitable. They include products like dried cannabis flower for vaporisation and bespoke oil formulations. While they haven’t undergone full UK licensing, they must still meet MHRA standards for safety and quality. Specialists can prescribe these products, which are either imported or produced locally.
NHS access to medical cannabis remains limited to the three licensed medicines for specific conditions. However, private clinics can prescribe a broader range of unlicensed CBPMs for conditions where there’s evidence they may help. Understanding this distinction is crucial when exploring the roles of THC and CBD in treatment.
THC vs CBD: What You Need to Know
Medical cannabis products are formulated with varying levels of THC (tetrahydrocannabinol) and CBD (cannabidiol), the two primary active compounds. The ratio of these compounds is tailored to the condition being treated.
THC-dominant products are often prescribed for their pain-relieving, appetite-stimulating, and muscle-relaxing properties. THC interacts with the body’s endocannabinoid system to reduce pain and inflammation, making it particularly beneficial for chronic pain conditions. It’s also effective in easing nausea and boosting appetite, which can be crucial for patients undergoing chemotherapy or living with conditions like HIV/AIDS.
CBD-focused products are valued for their anti-inflammatory, anti-anxiety, and anti-seizure properties. They are commonly prescribed for managing anxiety, stress, and depression, as well as aiding sleep in individuals with insomnia. CBD’s calming effects make it a useful option for conditions like PTSD and other mental health concerns.
Many medical cannabis formulations combine THC and CBD in specific ratios to suit individual needs. For instance, Sativex provides a balanced mix of both compounds in an oromucosal spray. Whether a patient requires a THC-dominant, CBD-dominant, or balanced product depends on their specific condition and how they respond to treatment. Finding the right ratio is essential for effective care.
Elios Clinics focuses on treating conditions such as chronic pain, neurological disorders, and psychiatric issues. Their specialists assess each patient’s unique situation to recommend the most suitable cannabinoid profile and dosage. All products must meet strict safety requirements.
Safety and Quality Standards
After selecting the appropriate product, ensuring its safety and quality is essential. In the UK, medical cannabis products – whether licensed or unlicensed – must comply with stringent regulatory standards enforced by the Medicines and Healthcare products Regulatory Agency (MHRA).
Unlicensed CBPMs are also subject to these regulations, which include robust pharmacovigilance measures to monitor safety once the products reach patients. Additionally, private clinics prescribing these products are regulated by the Care Quality Commission (CQC) to ensure high standards of care. All prescribing doctors must be registered specialists with the General Medical Council, providing another layer of oversight.
The supply chain for medical cannabis further upholds these standards. Once a prescription is approved, it is sent to a specialist pharmacy where the products are stored securely and packaged correctly. Secure couriers then deliver the medicine to patients, ensuring its integrity throughout the process.
Whether you’re prescribed a licensed medicine like Epidyolex or an unlicensed CBPM from a private clinic, you can be assured that the product has undergone rigorous checks. Clear labelling, dosing instructions, and safety warnings accompany each product, helping patients use them correctly and understand potential side effects.
Follow-up appointments are an integral part of the treatment process. These allow healthcare providers to monitor the effectiveness of the treatment, address any side effects, and ensure your safety throughout your medical cannabis journey.
sbb-itb-24979b8
How to Get Medical Cannabis in the UK (Step-by-Step Guide 2025)
Costs and Payment Options for Medical Cannabis
Once the clinical pathway is clear, the next step for patients is understanding the financial side of medical cannabis treatment. Costs can vary significantly depending on whether care is accessed through the NHS or private clinics.
NHS vs Private Clinic Costs
Accessing medical cannabis through the NHS is extremely limited and free for patients who meet strict NICE-approved criteria. Currently, only three licensed medications are available: Sativex for multiple sclerosis spasticity, Epidyolex for severe epilepsy, and Nabilone for chemotherapy-induced nausea. However, NHS prescriptions for these are rare, with estimates suggesting that 99% of patients rely on alternative sources due to the lack of availability on the NHS.
For most patients, private clinics are the main route to obtaining medical cannabis, but this comes at a cost. Initial consultations typically range from £50 to £200, follow-up appointments cost between £50 and £100, and monthly medication expenses fall between £150 and £500.
To put this into perspective, a patient managing chronic pain might pay around £99 for their first consultation, £75 for follow-ups, and approximately £250 per month for medication. These expenses can quickly accumulate, making affordability a key consideration.
This financial burden has led private clinics, such as Elios Clinics, to offer flexible payment plans to help patients manage costs.
Elios Clinics Pricing Plans
Elios Clinics provides straightforward pricing and payment options tailored to different budgets:
- Quarterly Subscription Plan: Priced at £60 per quarter as part of a 12-month programme, totalling £240 annually. This includes an initial consultation, four follow-up appointments, monthly prescriptions, access to a patient dashboard, and one document request.
- Monthly Subscription Plan: Costs £20 per month, also totalling £240 annually, offering smaller, regular payments for added flexibility.
- Pay As You Go: For new patients, the initial assessment and treatment plan design cost £50. Follow-up consultations and prescriptions are charged separately.
- Follow-up Consultations: Each session costs £50 for ongoing treatment monitoring and dose adjustments. Repeat prescriptions are free if ordered within the care pathway, or £30 if changes are required. Travel documents for medical cannabis are available for £10 each.
"At Elios Clinic, we know that medical cannabis treatment can add up over time, and we’re here to help! We make it a priority to keep our prices fair and easy to understand." – Elios Clinic
Access Options Comparison
When comparing NHS and private treatment, there are clear differences in costs, payment methods, and flexibility.
| Aspect | NHS Treatment | Private Treatment |
|---|---|---|
| Cost | Free at the point of use | £150–£500+ monthly plus consultation fees |
| Payment Options | Not applicable | Debit/credit cards, bank transfers, direct debit |
| Subscription Plans | Not available | Monthly and quarterly options available |
| Follow-up Costs | Free | £50–£100 per session |
While NHS treatment is free for those who meet the strict criteria, it is limited to a few licensed products like Sativex and Epidyolex. Most private prescriptions involve unlicensed products, which are not covered by the NHS and often come with higher costs due to import and regulatory fees. Despite 72% of the British public supporting medical cannabis, NHS access remains highly restricted.
Private clinics offer more flexible payment methods, including debit and credit cards, bank transfers, and direct debit for subscription plans. Patients concerned about costs should discuss all available options with their clinic, such as exploring lower-cost alternatives, adjusting the frequency of follow-ups, or checking for financial support schemes.
Key Points About Medical Cannabis Eligibility
Eligibility Requirements Summary
In the UK, to qualify for medical cannabis, patients must have a diagnosed condition that has not responded to at least two conventional treatments. While there are no legal age restrictions for prescriptions, clinics generally exercise greater caution with patients under 25. For individuals under 18, a referral to a paediatric specialist is mandatory.
Conditions that may be treated include chronic pain, PTSD, anxiety, depression, irritable bowel syndrome, fibromyalgia, Crohn’s disease, insomnia, and opioid withdrawal. At Elios Clinics, the focus is on managing chronic pain, as well as psychiatric and neurological conditions.
If you meet these criteria, you’re ready to take the next step towards your assessment.
Next Steps for Patients
Meeting the eligibility requirements means you can begin the process without needing a GP referral. Clinics like Elios Clinics allow you to book directly by completing a free eligibility assessment, which reviews your medical history and previous treatments.
Once deemed eligible, patients usually receive an invitation to book an appointment within three working days of submitting the required records. For those in England, using the NHS login can help speed up the application process.
The consultation itself is conducted via video with GMC-approved doctors. During this appointment, your medical history, current symptoms, and past treatments are reviewed. If approved, a personalised treatment plan is created, and medication is delivered as quickly as the next day.
Final Thoughts on Medical Cannabis Access
For those who have not found relief through conventional treatments, medical cannabis offers a real opportunity for improvement. At Elios Clinics, treatments are tailored to each patient’s needs, with ongoing support provided throughout the process. However, it’s important to note that results can vary – some patients may notice gradual improvements, while others might require several months to see optimal benefits.
Be mindful of driving regulations. THC can stay detectable in the blood for over 28 days, and the legal limit is just 2 micrograms/L. Always discuss any potential impairment with your specialist doctor, and never drive if you feel impaired.
FAQs
What is the process for getting assessed and prescribed medical cannabis at a private clinic in the UK?
The process of acquiring medical cannabis through a private clinic like Elios Clinics is designed to be simple and centred around your needs. It begins with booking an initial consultation, which can be done online or over the phone. During this appointment, you’ll have the opportunity to discuss your medical history and symptoms with a healthcare professional.
A qualified doctor will then evaluate your condition to determine if medical cannabis is a suitable option for you. If approved, you’ll receive a tailored treatment plan that includes details about the recommended strain, dosage, and clear usage instructions. Once your prescription is finalised, your medication will be conveniently delivered to your doorstep, often as quickly as the next day.
Elios Clinics places a strong emphasis on quality, safety, and patient care, ensuring you feel supported throughout the entire process.
What are the costs and payment options for medical cannabis treatment in private clinics compared to the NHS?
The cost of medical cannabis treatment in private clinics can vary greatly compared to NHS services, primarily because the NHS rarely prescribes medical cannabis. Private clinics, such as Elios Clinics, strive to make treatment more accessible by offering clear pricing and flexible payment plans.
At Elios Clinics, patients can expect services like eligibility assessments, consultations with GMC-approved doctors, and next-day delivery of prescribed medication. While private clinic costs are typically higher than NHS prescriptions, they focus on providing personalised care and convenience tailored to each patient’s needs.
What’s the difference between THC and CBD in medical cannabis, and how can they impact treatment for different conditions?
THC (tetrahydrocannabinol) and CBD (cannabidiol) are the two main active ingredients found in medical cannabis, each with unique effects. THC is known for its psychoactive properties and is commonly used to address issues like chronic pain, nausea, and muscle spasms. In contrast, CBD is non-psychoactive and is often chosen for its ability to ease inflammation, anxiety, and seizures.
At Elios Clinics, treatments are individually designed to suit each patient’s specific condition. By carefully balancing THC and CBD, they aim to maximise therapeutic results while keeping side effects to a minimum. This tailored approach ensures patients receive care that’s truly suited to their unique needs.
Related Blog Posts
About author
